PATENT CLAIM ANALYSIS

Application Number: 16090142
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "250000"]

Abstract:
The invention provides methods for the prophylaxis or treatment of one or more disorders associated with dementia comprising administering to a patient in need thereof, a therapeutically effective amount of (i) a 5-HT2A or 5-HT2A/D2 receptor ligand and (ii) a PDE1 inhibitor, and pharmaceutical compositions comprising (i) a 5-HT2A or 5-HT2A/D2 receptor ligand and (ii) a PDE1 inhibitor.

Claim (Index 12):
The method of  claim 1 , wherein the one or more disorders associated with dementia are selected from disorders associated with mild to severe cognition impairment and dementing illnesses including senile dementia, Alzheimer's disease, Pick's disease, frontotemporal dementia, parasupranculear palsy, dementia with Lewy bodies, vascular dementia, Huntington's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, Down syndrome, elderly depression, Wernicke-Korsakoff's syndrome, corticobasal degenerations, and prion disease.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 97.0
- Lexical Diversity: 1.64286
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14399334', '15977166', '14885813', '14066987', '14409866']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7930099956688114
- 35 USC 102 Novelty (BERT): 0.5173004317544297
- Combined Prediction Score: 0.7654390392773732
- Mean Citation Score: 271.499892
- Max Citation Score: 273.0258
- Similarity Product: 164.79330238895415

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test